319 related articles for article (PubMed ID: 25573386)
1. Reinnervation following catheter-based radio-frequency renal denervation.
Booth LC; Nishi EE; Yao ST; Ramchandra R; Lambert GW; Schlaich MP; May CN
Exp Physiol; 2015 Apr; 100(5):485-90. PubMed ID: 25573386
[TBL] [Abstract][Full Text] [Related]
2. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep.
Booth LC; Nishi EE; Yao ST; Ramchandra R; Lambert GW; Schlaich MP; May CN
Hypertension; 2015 Feb; 65(2):393-400. PubMed ID: 25403610
[TBL] [Abstract][Full Text] [Related]
3. Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats.
Mulder J; Hökfelt T; Knuepfer MM; Kopp UC
Am J Physiol Regul Integr Comp Physiol; 2013 Apr; 304(8):R675-82. PubMed ID: 23408032
[TBL] [Abstract][Full Text] [Related]
4. Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation.
Singh RR; McArdle ZM; Iudica M; Easton LK; Booth LC; May CN; Parkington HC; Lombardo P; Head GA; Lambert G; Moritz KM; Schlaich MP; Denton KM
Hypertension; 2019 Mar; 73(3):718-727. PubMed ID: 30661475
[TBL] [Abstract][Full Text] [Related]
5. Emerging topics on renal denervation in hypertension: anatomical and functional aspects of renal nerves.
Katsurada K; Kario K
Hypertens Res; 2023 Jun; 46(6):1462-1470. PubMed ID: 36991064
[TBL] [Abstract][Full Text] [Related]
6. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
Esler M
J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
[TBL] [Abstract][Full Text] [Related]
7. Renal Afferents.
Frame AA; Carmichael CY; Wainford RD
Curr Hypertens Rep; 2016 Sep; 18(9):69. PubMed ID: 27595156
[TBL] [Abstract][Full Text] [Related]
8. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension].
Mahfoud F; Böhm M
Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of catheter-based renal denervation on cardiac sympathetic drive and cardiac baroreflex function in heart failure.
Booth LC; Schlaich MP; Nishi EE; Yao ST; Xu J; Ramchandra R; Lambert GW; May CN
Int J Cardiol; 2015; 190():220-6. PubMed ID: 25920032
[TBL] [Abstract][Full Text] [Related]
10. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
Voora R; Hinderliter AL
Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
[TBL] [Abstract][Full Text] [Related]
12. Renal sensory nerves increase sympathetic nerve activity and blood pressure in 2-kidney 1-clip hypertensive mice.
Ong J; Kinsman BJ; Sved AF; Rush BM; Tan RJ; Carattino MD; Stocker SD
J Neurophysiol; 2019 Jul; 122(1):358-367. PubMed ID: 31091159
[TBL] [Abstract][Full Text] [Related]
13. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.
Kandzari DE; Bhatt DL; Sobotka PA; O'Neill WW; Esler M; Flack JM; Katzen BT; Leon MB; Massaro JM; Negoita M; Oparil S; Rocha-Singh K; Straley C; Townsend RR; Bakris G
Clin Cardiol; 2012 Sep; 35(9):528-35. PubMed ID: 22573363
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiological basis of renal nerve ablation for the treatment of hypertension.
Ziakas A; Gossios T; Doumas M; Karali K; Megarisiotou A; Stiliadis I
Curr Vasc Pharmacol; 2014 Jan; 12(1):23-9. PubMed ID: 23905601
[TBL] [Abstract][Full Text] [Related]
15. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW
Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066
[TBL] [Abstract][Full Text] [Related]
16. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
Schlaich MP
Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
[TBL] [Abstract][Full Text] [Related]
17. Anatomic Patterns of Renal Arterial Sympathetic Innervation: New Aspects for Renal Denervation.
Imnadze G; Balzer S; Meyer B; Neumann J; Krech RH; Thale J; Franz N; Warnecke H; Awad K; Hayek SS; Devireddy C
J Interv Cardiol; 2016 Dec; 29(6):594-600. PubMed ID: 27687514
[TBL] [Abstract][Full Text] [Related]
18. Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.
Hoogerwaard AF; de Jong MR; Elvan A
Curr Hypertens Rep; 2018 Mar; 20(3):24. PubMed ID: 29556850
[TBL] [Abstract][Full Text] [Related]
19. Renal sympathetic denervation and renal physiology.
Kalaitzidis RG; Karasavvidou D; Siamopoulos KC
Curr Clin Pharmacol; 2013 Aug; 8(3):189-96. PubMed ID: 23173964
[TBL] [Abstract][Full Text] [Related]
20. Renal Denervation to Modify Hypertension and the Heart Failure State.
Zhong M; Kim LK; Swaminathan RV; Feldman DN
Interv Cardiol Clin; 2017 Jul; 6(3):453-464. PubMed ID: 28600097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
